glp-1 drugs wegovy Researchers move closer to matching patients with drug that works best for them A new wave of weight-loss

Clinical trials investigating the newly approved GLP-1RA semaglutide for the treatment of NASH are currently ongoing

Cognitive function

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids

Its our way of making sure that every scoop does some good in the world

In a recent study, Liskiewicz and colleagues discovered that long-acting GIP receptor agonists activate GABAergic neurons that express the GIP receptor in the area postrema, and that GIP receptor signaling in GABAergic neurons is necessary for the effects of GIP to lower body weight [151]